Frequent OCT controls are needed to monitor disease activity in anti-VEGF therapy under real-life conditions. This poses a significant burden and may promote non-adherence. OCT home-monitoring could alleviate this burden and lead to earlier relapse recognition. However, today’s devices are not suited because they are not self-operable and too expensive. Self-examination OCT is a novel OCT technology that reduces complexity and thereby allows for a low-cost design. It was shown that a self-examination OCT prototype could be used by real-life patients for image self-acquisition.
Reference:
von der Burchard C, Moltmann M, Tode J, Ehlken C, Sudkamp H, Theisen-Kunde D, König I, Hüttmann G, Roider J. Self-examination low-cost full-field OCT (SELFF-OCT) for patients with various macular diseases. Graefes Arch Clin Exp Ophthalmol. 2020 Dec 21. doi: 10.1007/s00417-020-05035-6.https://pubmed.ncbi.nlm.nih.gov/33346888/
